Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K-C Li

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Virology Journal|March 22, 2024
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccinationSamuel M S Cheng, Chris K P Mok, John K C Li, et al.
Frontiers in Immunology|March 23, 2023
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescentsDaniel Leung, Carolyn A Cohen, Xiaofeng Mu, et al.
The Lancet. Microbe|August 7, 2023
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trialNancy H L Leung, Samuel M S Cheng, Carolyn A Cohen, et al.
Nature Communications|June 28, 2022
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescentsJaime S Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Signal Transduction and Targeted Therapy|December 14, 2022
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescentsXiaofeng Mu, Carolyn A Cohen, Daniel Leung, et al.
World Journal of Pediatrics : WJP|December 12, 2023
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescentsJaime S Rosa Duque, Samuel M S Cheng, Carolyn A Cohen, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Virology Journal|March 22, 2024
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccinationSamuel M S Cheng, Chris K P Mok, John K C Li, et al.
Frontiers in Immunology|March 23, 2023
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescentsDaniel Leung, Carolyn A Cohen, Xiaofeng Mu, et al.
The Lancet. Microbe|August 7, 2023
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trialNancy H L Leung, Samuel M S Cheng, Carolyn A Cohen, et al.
Nature Communications|June 28, 2022
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescentsJaime S Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Signal Transduction and Targeted Therapy|December 14, 2022
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescentsXiaofeng Mu, Carolyn A Cohen, Daniel Leung, et al.
World Journal of Pediatrics : WJP|December 12, 2023
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescentsJaime S Rosa Duque, Samuel M S Cheng, Carolyn A Cohen, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Pageof 15